a late (postnatal) increase in ossification. To mimic GSK-3b or Axin2 loss, we are over-expressing a drug-stabilised b-catenin construct in wild-type skull osteoblast cultures, and in skull explant (calvarial) cultures. Using a drug-dependent b-catenin will allow us to investigate the threshold levels of Wnt signalling required for ossification and the stages at which the b-catenin signal is critical for osteoblast differentiation. Our findings from these investigations will be reported here. Overexpression and knockdown analysis of snoN1, snoN2, and 
show that Jagged2 prevents Olig2 expression to be extinguished from the pMN, thus inhibiting oligodendrocyte differentiation by activating Hes5. Together these results show that Jagged2 function is required to preserve precursors at the pMN, until the second gliogenic phase takes place and oligodendrocytes are generated, and that Shh activity is required to control Jagged2 expression at pMN. Additionally, by RNA microarray-analysis of laser-microdissected intrapulmonary epithelium we identified 218 potential target genes which were affected either by loss of-Dll1, or after Notch-inhibition, or under both conditions. These genes are cur- 
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The apical-basal polarity kinase aPKC functions as a nuclear determinant and regulates cell proliferation and fate during 
